Outcomes of Infant Medulloblastoma Treated With Standard‐Dose Chemotherapy—A Single‐Institution Experience From a Low‐Middle‐Income Country
Managing medulloblastoma in infants is challenging in LMIC, as a significant proportion of families opt against postoperative treatment. Although traditionally considered high risk, good survival can be achieved with non-intensified therapy without an increase in treatment-related mortality, especially in patients with DN/MBEN histology.
Authors
- Ranjith K. Moorthy (ORCID: https://orcid.org/0000-0002-6679-3483)
- Patricia Sebastian (ORCID: https://orcid.org/0000-0001-9347-1802)
- Krishnaprabhu Raju (ORCID: https://orcid.org/0000-0002-2644-7201)
- Rikki R. John (ORCID: https://orcid.org/0000-0001-5547-5829)
- Gnanamani Senguttuvan
- Leni G. Mathew (ORCID: https://orcid.org/0000-0003-1386-6316)
- Geeta Chacko (ORCID: https://orcid.org/0000-0002-2705-4717)
- Ranjani Jayachandran (ORCID: https://orcid.org/0000-0002-4538-9393)
- Rajesh Balakrishnan (ORCID: https://orcid.org/0000-0001-8387-9716)
- Baylis Vivek Joseph (ORCID: https://orcid.org/0000-0002-2320-7384)
- Leenu Lizbeth Joseph
Institutions
- Christian Medical College, Vellore (IN)
Publication Details
- Journal
- Pediatric Blood & Cancer
- Published
- 2025-09-22
- DOI
- https://doi.org/10.1002/pbc.32056
- Primary Topic
- Glioma Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00